CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

What is the Future of Supply Chain in the Life Science Sector?

Life Sciences Review | Friday, April 10, 2020
Tweet

The life science sector is trying to localize their supply chain and reduce the dependency on other countries.


FREMONT, CA: The life science sector is going through immense changes and disruption. Moreover, the industry companies are also moving towards localization because it does not want to depend on other countries to gain some benefit. The companies are also focusing on the supply chain's security because they are slowly decreasing their dependency on outsourcing it to other countries to get the cost advantage.


The localization of the life science sector


Localizing in the life science sector is not a new concept, but it is increasing in recent times. The life science companies are looking forward to bringing back elements of products in their local markets. It is also necessary for them to develop a presence in the worldwide market.


However, the large pharma, medical device, or biotech organizations have to increase their capabilities to meet the local market's requirements to develop drug security with full production and distribution locally. Although it is virtually impossible to decrease the dependency on well-established trading relationships overnight, the companies are trying their best. 


It might take the life science companies months or years to stop utilizing their API supplier or move a drug to a local manufacturing center.


The companies can also increase their capabilities to discretely serve the local markets even while utilizing a global supply model where it seems accurate. The outcome might not end the global supply chains, but it will develop a multi-layered ecosystem with the small local supply chains connected to a worldwide backbone for the large companies. However, it will be necessary to apply a new supply chain visibility, communication, and collaboration level.


The growth of CDMOs


During the pandemic of COVID-19, one sector of the life science has witnessed extreme growth, and it is the Contract Development and Manufacturing Organization (CDMO) market. it is also estimated that CDMOs change will increase in the future.


The life science companies have increased their partnering with CDMOs because of the high demand for production to meet objectives like localization while prioritizing cost and revenue. Many governments are also trying to incentivize the utilization of CDMOs to drive the country's production. Therefore, the organizations will increase their investment in CDMOs to accelerate their presence in the global market at a reduced cost.


See Also: Top Pharma Supply Chain Technology companies


Weekly Brief

loading
Towards a New World Order
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/what-is-the-future-of-supply-chain-in-the-life-science-sector-nwid-114.html